About this trial
To assess the feasibility of an expedited referral process for the obese endometrial cancer or EIN patient from her gynecologic oncologist to the Brigham Center for Metabolic and Bariatric Surgery (CMBS) in order to undergo concurrent weight loss surgery and hysterectomy within 8 weeks of first appointment with a gynecologic oncologist (or 12 weeks for EIN patients).
Eligibility criteria
Qualifiers
Female adults at least 18 years of age
A BMI of 35-39.99 and 1 or more severe obesity-related co-morbidities
Tissue diagnosis (usually endometrial biopsy) of grade 1 endometrial carcinoma or EIN.
Disqualifiers
Younger than 18 years old
BMI < 35
Without a tissue diagnosis, or with a grade 2 or greater endometrial cancer tissue diagnosis
Pregnant participants will be excluded from this study.
Trial design
Treatments tested in this trial
- CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral
Treatment groups
Sponsors and collaborators
Dana-Farber Cancer Institute
Lead sponsor
Brigham and Women's Hospital
Sponsor institution